David S. Maxwell

21.5k total citations · 1 hit paper
88 papers, 16.1k citations indexed

About

David S. Maxwell is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, David S. Maxwell has authored 88 papers receiving a total of 16.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 18 papers in Cellular and Molecular Neuroscience and 14 papers in Neurology. Recurrent topics in David S. Maxwell's work include Neuroscience and Neuropharmacology Research (13 papers), Barrier Structure and Function Studies (12 papers) and Neurogenesis and neuroplasticity mechanisms (9 papers). David S. Maxwell is often cited by papers focused on Neuroscience and Neuropharmacology Research (13 papers), Barrier Structure and Function Studies (12 papers) and Neurogenesis and neuroplasticity mechanisms (9 papers). David S. Maxwell collaborates with scholars based in United States, Israel and United Kingdom. David S. Maxwell's co-authors include William L. Jorgensen, Julian Tirado‐Rives, Lawrence Kruger, David W. Caley, Alan L. Shabo, Daniel C. Pease, John D. Green, Reed A. Rowan, W.J. Schindler and Christian Stumpf and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

David S. Maxwell

87 papers receiving 15.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids

1996 12.5k citations David S. Maxwell et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David S. Maxwell United States	34	5.2k	3.3k	2.7k	2.2k	2.0k	88	16.1k
Hsing Lee United States	7	10.3k 2.0×	3.5k 1.1×	3.6k 1.4×	2.3k 1.0×	2.5k 1.2×	8	19.2k
Romain M. Wolf Switzerland	26	9.9k 1.9×	3.1k 0.9×	1.8k 0.7×	1.4k 0.6×	2.9k 1.5×	57	18.1k
Ulrich Essmann United States	15	10.4k 2.0×	5.2k 1.5×	4.4k 1.7×	3.2k 1.5×	2.4k 1.2×	17	21.2k
J. G. E. M. Fraaije Netherlands	26	9.0k 1.7×	4.3k 1.3×	2.0k 0.7×	1.7k 0.8×	2.7k 1.4×	84	17.4k
Henk Bekker Netherlands	11	9.0k 1.7×	2.5k 0.8×	1.9k 0.7×	1.5k 0.7×	1.9k 0.9×	20	15.5k
Barry D. Olafson United States	10	10.2k 2.0×	6.0k 1.8×	3.1k 1.2×	1.6k 0.7×	1.9k 0.9×	13	19.3k
J.R. Haak Netherlands	10	12.0k 2.3×	7.0k 2.1×	5.0k 1.9×	3.1k 1.4×	2.7k 1.4×	11	26.0k
Ian R. Gould United Kingdom	47	10.1k 1.9×	4.5k 1.3×	4.3k 1.6×	1.4k 0.6×	3.6k 1.8×	156	19.4k
David M. Ferguson United States	40	11.4k 2.2×	3.6k 1.1×	3.0k 1.1×	1.4k 0.7×	2.4k 1.2×	116	19.6k
Gerrit Groenhof Finland	39	9.5k 1.8×	3.2k 1.0×	3.5k 1.3×	2.1k 0.9×	2.0k 1.0×	87	18.7k

Countries citing papers authored by David S. Maxwell

Since Specialization

Citations

This map shows the geographic impact of David S. Maxwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Maxwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Maxwell more than expected).

Fields of papers citing papers by David S. Maxwell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Maxwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Maxwell. The network helps show where David S. Maxwell may publish in the future.

Co-authorship network of co-authors of David S. Maxwell

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Maxwell. A scholar is included among the top collaborators of David S. Maxwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Maxwell. David S. Maxwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Woodside, Darren G., Eric A. Tanifum, Ketan B. Ghaghada, et al.. (2018). Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin α4β1. Scientific Reports. 8(1). 3733–3733. 27 indexed citations

Leonard, Paul G., Nikunj Satani, David S. Maxwell, et al.. (2016). SF2312 is a natural phosphonate inhibitor of enolase. Nature Chemical Biology. 12(12). 1053–1058. 73 indexed citations

Peng, Zhenghong, David S. Maxwell, Duoli Sun, et al.. (2014). Degrasyn-like symmetrical compounds: Possible therapeutic agents for multiple myeloma (MM-I). Bioorganic & Medicinal Chemistry. 22(4). 1450–1458. 12 indexed citations

Arumugam, Thiruvengadam, Vijaya Ramachandran, Duoli Sun, et al.. (2013). Designing and Developing S100P Inhibitor 5-Methyl Cromolyn for Pancreatic Cancer Therapy. Molecular Cancer Therapeutics. 12(5). 654–662. 41 indexed citations

Peng, Zhenghong, David S. Maxwell, Duoli Sun, et al.. (2013). Imatinib analogs as potential agents for PET imaging of Bcr-Abl and c-KIT expression at a kinase level. Bioorganic & Medicinal Chemistry. 22(1). 623–632. 14 indexed citations

Sun, Duoli, Zhenghong Peng, David S. Maxwell, et al.. (2013). Improved synthesis of 17β-hydroxy-16α-iodo-wortmannin, 17β-hydroxy-16α-iodoPX866, and the [131I] analogue as useful PET tracers for PI3-kinase. Bioorganic & Medicinal Chemistry. 21(17). 5182–5187. 4 indexed citations

Vanderslice, Peter, Darren G. Woodside, Wells S. Brown, et al.. (2013). Small Molecule Agonist of Very Late Antigen-4 (VLA-4) Integrin Induces Progenitor Cell Adhesion. Journal of Biological Chemistry. 288(27). 19414–19428. 20 indexed citations

Angelo, Laura S., David S. Maxwell, Ji Yuan Wu, et al.. (2012). Binding partners for curcumin in human schwannoma cells: Biologic Implications. Bioorganic & Medicinal Chemistry. 21(4). 932–939. 18 indexed citations

Kapuria, Vaibhav, Alexander Levitzki, William G. Bornmann, et al.. (2011). A novel small molecule deubiquitinase inhibitor blocks Jak2 signaling through Jak2 ubiquitination. Cellular Signalling. 23(12). 2076–2085. 39 indexed citations

10.

Peng, Zhenghong, Ashutosh Pal, Dongmei Han, et al.. (2011). Tyrphostin-like compounds with ubiquitin modulatory activity as possible therapeutic agents for multiple myeloma. Bioorganic & Medicinal Chemistry. 19(23). 7194–7204. 6 indexed citations

11.

Thomas, Robert, Neel Sharma, Christopher J. Burke, David S. Maxwell, & David Howlett. (2010). Parotid incidentaloma detected during thoracic PET imaging: how should these lesions be managed?. British Journal of Hospital Medicine. 71(5). 292–293. 9 indexed citations

12.

Najjar, Amer, Ryuichi Nishii, David S. Maxwell, et al.. (2009). Molecular–Genetic PET Imaging Using an HSV1-tk Mutant Reporter Gene with Enhanced Specificity to Acycloguanosine Nucleoside Analogs. Journal of Nuclear Medicine. 50(3). 409–416. 20 indexed citations

13.

Bommarius, Bettina, David S. Maxwell, Alyson Swimm, et al.. (2007). Enteropathogenic Escherichia coli Tir is an SH2/3 ligand that recruits and activates tyrosine kinases required for pedestal formation. Molecular Microbiology. 63(6). 1748–1768. 49 indexed citations

14.

O’Brian, Catherine A., F. Chu, William G. Bornmann, & David S. Maxwell. (2006). Protein kinase Cα and ε small-molecule targeted therapeutics: a new roadmap to two Holy Grails in drug discovery?. Expert Review of Anticancer Therapy. 6(2). 175–186. 15 indexed citations

15.

Pal, Ashutosh, Athanasios Glekas, Mikhail Doubrovin, et al.. (2006). Molecular Imaging of EGFR Kinase Activity in Tumors with 124I-Labeled Small Molecular Tracer and Positron Emission Tomography. Molecular Imaging and Biology. 8(5). 262–277. 77 indexed citations

16.

Maxwell, David S.. (2004). Operation Enduring Freedom-Philippines: What Would Sun Tzu Say?. Military review. 84(3). 20. 3 indexed citations

17.

Maxwell, David S.. (2004). A Strategy for the Korean Peninsula: Beyond the Nuclear Crisis. Military review. 84(5). 103. 3 indexed citations

18.

Maxwell, David S.. (2004). THE SEEDS OF TERROR: An Eye-Witness Account of Al-Qaeda's Newest Center of Operations in Southeast Asia. Military review. 84(4). 96. 16 indexed citations

19.

Maxwell, David S., Timothy P. Kogan, Jian Li, et al.. (2002). A 3D Structure Model of Integrin α4β1 Complex: I. Construction of a Homology Model of β1 and Ligand Binding Analysis. Biophysical Journal. 82(1). 447–457. 21 indexed citations

20.

Green, John D. & David S. Maxwell. (1961). Hippocampal electrical activity I. Morphological aspects. Electroencephalography and Clinical Neurophysiology. 13(6). 837–846. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact